Bonafide Women’s Health LLC recently added to its more than 50 women’s health supplement formulations by acquiring a proprietary SAM-e ingredient from Canadian firm MSI Methylation Sciences Inc.
MSI Methylation sold its S-adenosyl-L-methionine ingredient, a controlled-release tablet identified as MSI-195, after conducting a study on its safety and...





